Financial results: Bioxyne; Melodiol Global Health; Emyria; Zelira; Elixinol; Wellnex Life; Argent BioPharma by Steve Jones May 1, 2024May 1, 2024 Revenue generated by Breathe Life Sciences (BLS) slipped to A$1.7 million in Q3 FY24 with parent […]
Company news: Bioxyne/BLS; Rua Bioscience; Botanix; Melodiol Global Health; Zelira; Argent BioPharma by Martin Lane and Steve Jones April 16, 2024April 18, 2024
Health House to open its own telehealth clinic this quarter by Martin Lane April 9, 2024April 9, 2024
Company news: LGP/Reset; Melodiol; AusCann; Elixinol by Martin Lane February 21, 2024February 21, 2024
Company news: Bioxyne/BLS; Wellnex Life; Elixinol Wellness; Althea; Health House; Rua Bioscience by Steve Jones and Martin Lane February 7, 2024February 7, 2024
Quarterly results: Avecho; Melodiol; Bioxyne/BLS; Emyria; Ecofibre; Zelira; Elixinol; AusCann; Botanix by Steve Jones and Martin Lane January 31, 2024February 1, 2024
Melodiol flags possible sale of core assets to raise capital by Steve Jones December 11, 2023December 13, 2023
Company news: Emyria; Wellnex Life; Neurotech International; Melodiol Global Health by Martin Lane November 14, 2023April 30, 2024
Health House founder Paul Mavor ‘back in the pharmacy game’ by Martin Lane November 6, 2023April 30, 2024